Replies to post #790325 on NorthWest Biotherapeutics Inc (NWBO)

[jesster64]

"I also often add that this review process has been going on longer than anticipated. But given that our technology is a first-in-class and innovative cell therapy that the MHRA has never seen before it appears they are being extra careful in their review. I conclude that given our active engagement with them, every day that passes is a day closer to their decision."

There you have it. Nothing special, nothing extra, just the MHRA being extra careful. Don't read more into it than that.

[manibiotech]

Thanks 
So there goes the new narrative of the few, of short frequent exchanges indicating the very end  ( changed  from last stage of labeling, which was also proven wrong ) , out of the window .And BTW, swallows return to Capistrano in March. 

[seekinganswers]

So he basically told you NOTHING except the old "actively engaged" legal jargon line mentioned in the SEC filing. And you think you just boated a Blue Marlin.... LOL. Pathetic.

[ilovetech]

Lykiri - BP's benefit from having a
stacked advisory committee filled with panelists with former ties to the applicant.
I have the mRNA advisory panel (Zoom recorded minutes) consisting of 12 advisors, "all" with former ties to Pfizer.

Reply from George Zavoico.

But given that our technology is a first-in-class and innovative cell therapy that the MHRA has never seen before it appears they are being extra careful in their review. I conclude that given our active engagement with them, every day that passes is a day closer to their decision.

I'll leave it there.

[Investor082]

But you were pumping approval before end of May too. What happened there?

[dennisdave]

That means that NWBO is responding as quickly and efficiently as we can to their queries and requests for information. That’s all I can say about where we are with the MHRA.

well he is saying a hell of a lot less than when they PRed this a month ago

The consideration for the acquisition will be paid in installments over two years, beginning 90 days after the acquisition agreement, with potential acceleration after regulatory approval of the Company’s DCVax®-L product.

[AllSheWrote]

Of course this confirms that flipper44's post yesterday was complete BS, as I suspected. It also confirms that they are not sitting around waiting to hear from MHRA, as so many on here seem to think. They are trying to respond to MHRA's questions and are having a very hard time doing it, as I have been saying all along.